The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Business Wire

NYSE Euronext Announces Trading Volumes for November 2013

<p class='bwalignc'> <i>Global Derivatives ADV Up Year-over-Year and Month-over-Month, excluding Bclear</i> </p> <p class='bwalignc'> <i>European Cash Equities ADV Up Year-over-Year but Down Sequentially</i> </p> <p class='bwalignc'> <i>U.S. Cash ADV Down Year-over-Year and Down Sequentially</i> </p>

Wednesday, December 04, 2013

NYSE Euronext Announces Trading Volumes for November 2013

08:30 EST Wednesday, December 04, 2013

NEW YORK (Business Wire) -- NYSE Euronext (NYX) today announced trading volumes for its global derivatives and cash equities exchanges for November 20131. Global derivatives average daily volume (“ADV”) of 6.6 million contracts, excluding Bclear in November 2013 increased 1.6% compared to November 2012 and increased 1.7% from October 2013. U.S. equity options volumes in November 2013 decreased 7.8% compared to November 2012 and decreased 4.4% sequentially. ADV in U.S. cash equities declined 12.6% year-over-year and decreased 5.2% month-over-month. European cash equities ADV in November 2013 increased 14.4% compared to November 2012, but decreased 3.3% from October 2013 levels.

Highlights

  • NYSE Euronext global derivatives ADV in November 2013 of 6.6 million contracts, excluding Bclear increased 1.6% from November 2012 and increased 1.7% from October 2013 levels.
  • NYSE Euronext European derivatives products ADV in November 2013 of 2.8 million contracts, excluding Bclear, increased 18.7% compared to November 2012 and increased 11.3% from October 2013 levels. Including Bclear, NYSE Liffe's trade administration and clearing service for OTC products, European derivatives ADV decreased 19.1% compared to November 2012, but increased 10.9% from October 2013.
  • NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex Options) ADV of 3.7 million contracts in November 2013 decreased 7.8% compared to November 2012 levels and decreased 4.4% from October 2013 levels. NYSE Euronext's U.S. options exchanges accounted for 26.0% of total U.S. consolidated equity options trading in November 2013, down from 28.1% in November 2012, but up from 25.0% in October 2013.
  • NYSE Liffe U.S. ADV of approximately 32,300 contracts decreased from 51,500 contracts in November 2012, but increased from 29,900 contracts in October 2013.
  • NYSE Euronext European cash products ADV of 1.3 million transactions in November 2013 increased 14.4% compared to November 2012, but decreased 3.2% compared to October 2013.
  • NYSE Euronext U.S. cash products (NYSE, NYSE Arca and NYSE MKT) handled ADV of 1.4 billion shares in November 2013 decreased 12.6% compared to November 2012 and decreased 5.2 % compared to October 2013. NYSE Euronext's Tape A matched market share in November 2013 was 29.5%, down from 31.7% in November 2012, but up from 29.4% in October 2013.

Please click here for the Monthly Transaction Activity Data Table.

1   All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction. NYSE Euronext European equities transactions count each buy and sell order as separate transactions, NYSE Euronext U.S. equities transactions count buy and sell orders together as a single transaction.

About IntercontinentalExchange Group

IntercontinentalExchange Group (NYSE:ICE) is the leading network of regulated exchanges and clearing houses for financial and commodity markets. ICE delivers transparent, reliable and accessible data, technology and risk management services to markets around the world through its portfolio of exchanges, including the New York Stock Exchange, ICE Futures, Liffe and Euronext.

Trademarks of ICE and/or its affiliates include IntercontinentalExchange, ICE, ICE block design, NYSE Euronext, NYSE, New York Stock Exchange, LIFFE and Euronext. Information regarding additional trademarks and intellectual property rights of IntercontinentalExchange Group, Inc. and/or its affiliates is located at https://www.theice.com/terms.jhtml and http://www.nyx.com/terms-use.

Please follow us at:
Exchanges Blog
Facebook
LinkedIn
Twitter

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 - Statements in this press release regarding ICE's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see ICE's Securities and Exchange Commission (SEC) filings, including, but not limited to, the risk factors in ICE's Annual Report on Form 10-K for the year ended December 31, 2012, as filed with the SEC on February 6, 2013.

 

NYSE Euronext

Monthly Volume Summary

 
      Average Daily Volume     Total Volume     Average Daily Volume     Total Volume
(Unaudited; contracts in thousands) Nov-13   Nov-12   % Chg Nov-13   Nov-12   % Chg YTD 2013  

% Chg vs.
YTD 2012

YTD 2013  

% Chg vs.
YTD 2012

Number of Trading Days - European Cash 21 22 21 22 235 235
Number of Trading Days - European Derivatives 21 22 21 22 236 236
Number of Trading Days - U.S. Markets 20 21 20 21 231 231
European Derivatives Products 3,223 3,983 -19.1% 67,681 87,616 -22.8% 3,728 -0.2% 879,879 -1.1%

of which Bclear

429 1,630 -73.7% 9,014 35,857 -74.9% 636 -42.3% 150,176 -42.8%
 
Total Fixed Income Products 2,098 1,582 32.6% 44,062 34,803 26.6% 2,296 29.9% 541,910 28.8%
 
Short Term Interest Rate Products 1,896 1,376 37.8% 39,819 30,267 31.6% 2,121 31.5% 500,576 30.4%
Medium and Long Term Interest Rate Products 1 202 206 -2.0% 4,243 4,537 -6.5% 175 13.1% 41,334 12.2%
 
Total Equity Products 2 1,048 2,314 -54.7% 22,012 50,914 -56.8% 1,339 -28.8% 315,972 -29.4%
 
Individual Equity Products 647 1,884 -65.6% 13,594 41,457 -67.2% 856 -39.1% 202,124 -39.6%
Futures 292 1,521 -80.8% 6,139 33,454 -81.6% 468 -51.5% 110,389 -51.9%
Options 355 364 -2.4% 7,455 8,003 -6.9% 389 -12.3% 91,735 -13.0%
Equity Index Products 401 430 -6.7% 8,419 9,457 -11.0% 482 1.7% 113,848 0.9%
 

of which Bclear

427 1,630 -73.8% 8,974 35,857 -75.0% 635 -42.4% 149,866 -42.9%
Individual Equity Products 363 1,556 -76.7% 7,627 34,236 -77.7% 541 -47.4% 127,783 -47.9%
Futures 292 1,494 -80.4% 6,139 32,872 -81.3% 457 -51.4% 107,806 -51.8%
Options 71 62 14.3% 1,488 1,365 9.1% 85 -6.0% 19,977 -6.8%
Equity Index Products 64 74 -13.0% 1,346 1,621 -16.9% 94 27.7% 22,084 26.7%
 
Commodity Products 77 86 -11.3% 1,607 1,898 -15.3% 93 5.2% 21,997 4.3%
 
U.S. Derivatives Products
 
Equity Options 3
 

NYSE Euronext Options Contracts

3,749 4,068 -7.8% 74,974 85,423 -12.2% 4,000 2.7% 923,888 3.2%
Total Consolidated Options Contracts 14,394 14,488 -0.6% 287,887 304,256 -5.4% 14,874 0.7% 3,435,869 1.2%
 
NYSE Group Share of Total 26.0% 28.1% 26.0% 28.1% 26.9% 0.5% 26.9% 0.5%
 
NYSE Liffe U.S.
 
Futures and Futures Options Volume* 32.3 51.5 -37.4% 645 1,133 -43.0% 51.4 -29.4% 12,131.0 -29.9%
 
European Cash Products (trades in thousands) 1,338 1,170 14.4% 28,105 25,739 9.2% 1,388 -5.9% 326,280 -6.7%
 
Equities 1,294 1,122 15.3% 27,180 24,693 10.1% 1,340 -6.0% 314,994 -6.8%
Exchange-Traded Funds 12 12 0.2% 262 274 -4.3% 13 0.0% 3,164 -0.9%
Structured Products 27 29 -7.1% 572 644 -11.3% 30 -4.6% 7,022 -5.4%
Bonds 4 6 -25.2% 91 127 -28.6% 5 -10.2% 1,100 -11.0%
 
U.S. Cash Products (shares in millions) 5 1,385 1,585 -12.6% 27,699 33,284 -16.8% 1,509 -11.2% 348,488 -10.8%
 
NYSE Listed (Tape A) Issues 4
 
Handled Volume 5 980 1,132 -13.4% 19,605 23,772 -17.5% 1,076 -11.5% 248,481 -11.1%
Matched Volume 6 948 1,086 -12.7% 18,967 22,804 -16.8% 1,038 -10.1% 239,706 -9.7%
Total NYSE Listed Consolidated Volume 3,210 3,421 -6.1% 64,205 71,832 -10.6% 3,415 -7.3% 788,891 -6.9%
 
Share of Total Consolidated Volume
Handled Volume 5 30.5% 33.1% -2.6% 30.5% 33.1% -2.6% 31.5% -1.5% 31.5% -1.5%
Matched Volume 6 29.5% 31.7% -2.2% 29.5% 31.7% -2.2% 30.4% -0.9% 30.4% -0.9%
 
NYSE Arca, MKT and Regional (Tape B) Listed Issues
 
Handled Volume 5 220 235 -6.5% 4,396 4,936 -10.9% 248 -0.7% 57,279 -0.3%
Matched Volume 6 205 217 -5.9% 4,091 4,564 -10.4% 229 1.3% 52,880 1.8%
Total NYSE Arca & MKT Listed Consolidated Volume 916 1,010 -9.3% 18,315 21,213 -13.7% 1,073 1.0% 247,855 1.4%
 
Share of Total Consolidated Volume
Handled Volume 5 24.0% 23.3% 0.7% 24.0% 23.3% 0.7% 23.1% -0.4% 23.1% -0.4%
Matched Volume 6 22.3% 21.5% 0.8% 22.3% 21.5% 0.8% 21.3% 0.1% 21.3% 0.1%
 
Nasdaq Listed (Tape C) Issues
 
Handled Volume 5 185 218 -15.1% 3,698 4,576 -19.2% 185 -20.8% 42,728 -20.4%
Matched Volume 6 165 195 -15.2% 3,301 4,088 -19.3% 165 -17.9% 38,118 -17.6%
Total Nasdaq Listed Consolidated Volume 1,790 1,769 1.2% 35,800 37,152 -3.6% 1,761 0.4% 406,811 0.8%
 
Share of Total Consolidated Volume
Handled Volume 5 10.3% 12.3% -2.0% 10.3% 12.3% -2.0% 10.5% -2.8% 10.5% -2.8%
Matched Volume 6 9.2% 11.0% -1.8% 9.2% 11.0% -1.8% 9.4% -2.1% 9.4% -2.1%
 
Exchange-Traded Products 5,7
 
Handled Volume 5 198 225 -12.1% 3,956 4,727 -16.3% 231 -1.6% 53,410 -1.1%
Matched Volume 6 191 209 -8.7% 3,811 4,381 -13.0% 214 0.8% 49,432 1.2%
Total ETF Consolidated Volume 860 987 -12.9% 17,191 20,728 -17.1% 1,025 -0.3% 236,853 0.2%
 
Share of Total Consolidated Volume
Handled Volume 5 23.0% 22.8% 0.2% 23.0% 22.8% 0.2% 22.6% -0.3% 22.6% -0.3%
Matched Volume 6 22.2% 21.1% 1.1% 22.2% 21.1% 1.1% 20.9% 0.2% 20.9% 0.2%
 
 
1   Data includes currency products.

2

Includes all trading activities for Bclear, NYSE Liffe's clearing service for wholesale derivatives.
3 Includes trading in U.S. equity options contracts, not equity-index options.
4 Includes all volume executed in NYSE Group crossing sessions.
5 Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots.
6 Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges.
7 Data included in previously identified categories.
* ADVs calculated with the appropriate number of NYSE Liffe U.S. trading days.
Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities.
All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells.
 

NYSE Euronext
Media:
New York, +1-212-656-2411
or
Investor Relations:
New York, +1-212-656-5700
Atlanta, +1-770-857-0363

Products
  • Globe Unlimited

    Digital all access pass across devices. subscribe

  • The Globe and Mail Newspaper

    Newspaper delivered to your doorstep. subscribe

  • Globe2Go

    The digital replica of our newspaper. subscribe

  • Globe eBooks

    A collection of articles by the Globe. subscribe

See all Globe Products

Advertise with us

GlobeLink.ca

Your number one partner for reaching Canada's Influential Achievers. learn more

Digital Business Solutions
Our Company
Customer Service
Globe Recognition
Mobile Apps
NEWS APP
INVESTING APP
Other Sections